subject: UMLS:C0003442

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: childhood myelodysplastic syndrome

tested_intervention: yes


subject: UMLS:C0003442

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:8382

subject_name: Prednisone

object_name: Myelodysplasia

tested_intervention: unsure


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: obstructive sleep apnea syndrome


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:44915

subject_name: Propofol


subject: UMLS:C2984020

object_name: Plasma cell myeloma refractory


subject: UMLS:C2984020

object_name: Plasma cell myeloma recurrent


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: HIV infection


subject: UNII:MA10QYF1Z0

subject_name: Ferric maltol

object_name: iron deficiency anemia


subject: UNII:MA10QYF1Z0

object_name: Chronic uremia


subject: CHEBI:94187

subject_name: Givinostat

object_name: Drug Interactions


subject: CHEBI:4856

subject_name: Esmolol

object_name: Overdose of beta-adrenergic blocking drug


subject: CHEBI:4856

object_name: overdose


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON


subject: CHEMBL.COMPOUND:CHEMBL5314341


subject: CHEBI:5391

subject_name: Glucagon


subject: CHEBI:5391


subject: CHEBI:567361

subject_name: Cladribine

object_name: mantle cell lymphoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:52717

subject_name: Bortezomib


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: Metastatic non-small cell lung cancer


subject: UNII:2285XW22DR

object_name: Non-small cell lung cancer recurrent


subject: UNII:2285XW22DR

object_name: lung large cell carcinoma


subject: UNII:2285XW22DR

object_name: minimally invasive lung adenocarcinoma


subject: UNII:2285XW22DR

object_name: lung adenocarcinoma


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:6931

subject_name: Midazolam

object_name: cystic fibrosis


subject: UNII:6B7TYB2MJX

subject_name: Cudetaxestat


subject: UMLS:C5853745


subject: UNII:8F63U28T2V

subject_name: Imexon

object_name: plasma cell myeloma


subject: CHEBI:84500

subject_name: varenicline


subject: CHEBI:84500

object_name: Tabagism


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: neoplasm


subject: CHEBI:74926

subject_name: Patulin


subject: PUBCHEM.COMPOUND:23725028

subject_name: Stanate (TN)

object_name: Neonatal hyperbilirubinemia


subject: CHEMBL.COMPOUND:CHEMBL4297207

subject_name: STANNSOPORFIN


subject: CHEBI:48131

subject_name: Azelaic acid

object_name: Papulopustular Rosacea


subject: CHEBI:231087

subject_name: Trilaciclib

object_name: Childhood Breast Carcinoma


subject: CHEBI:231087

object_name: breast carcinoma


subject: CHEBI:231087

object_name: breast cancer


subject: CHEBI:231087

object_name: cervical cancer


subject: CHEBI:231087

object_name: cervical carcinoma


subject: CHEBI:231087

object_name: endometrial cancer


subject: CHEBI:231087

object_name: uterine corpus cancer


subject: CHEBI:231087

object_name: endometrial carcinoma


subject: CHEBI:231087

object_name: non-small cell lung carcinoma


subject: CHEBI:231087

object_name: head and neck squamous cell carcinoma


subject: UNII:91X1KLU43E

subject_name: Golimumab

object_name: rheumatoid arthritis


subject: CHEBI:167574

subject_name: Semaglutide

object_name: cerebrovascular disorder


subject: CHEBI:167574

object_name: cardiovascular disorder


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: non-Hodgkin lymphoma


subject: UMLS:C1541395


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: bipolar disorder


subject: CHEBI:6367

object_name: bipolar depression


subject: CHEBI:58097

object_name: Fatty Liver


subject: CHEBI:17303

subject_name: Morphine


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Mentally ill chemical abuse


subject: PUBCHEM.COMPOUND:521372

object_name: Dual diagnosis (psychiatry)


subject: CHEBI:18132

subject_name: phosphocholine


subject: UniProtKB:Q62857

subject_name: DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


subject: PR:000006347

subject_name: DNA damage-inducible transcript 3 protein


subject: CHEBI:7903

subject_name: Pamidronic acid

object_name: spina bifida


subject: CHEBI:7903

object_name: Spina bifida without mention of hydrocephalus, site unspecified


subject: CHEBI:7903

object_name: neural tube defects, susceptibility to


subject: CHEBI:7903

object_name: osteogenesis imperfecta


subject: CHEBI:7903

object_name: cerebral palsy


subject: CHEBI:7903

object_name: osteoporosis


subject: CHEBI:7903

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:7903

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:7903

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:7903

object_name: Osteopenia


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: uveitis


subject: PUBCHEM.COMPOUND:70789204

object_name: Uveitis, CTCAE


subject: UNII:S7RL72610R

subject_name: gossypol acetic acid

object_name: adult glioblastoma


subject: UNII:S7RL72610R

object_name: Adult Giant Cell Glioblastoma


subject: UNII:S7RL72610R

object_name: Recurrent Adult Brain Neoplasm


subject: UNII:S7RL72610R

object_name: Adult Gliosarcoma


subject: PUBCHEM.COMPOUND:35450

subject_name: GOSSYPOL ACETIC ACID


subject: PUBCHEM.COMPOUND:35450


subject: PUBCHEM.COMPOUND:35450


subject: PUBCHEM.COMPOUND:35450


subject: PUBCHEM.COMPOUND:22327742

subject_name: Gosspyl acetate


subject: PUBCHEM.COMPOUND:22327742


subject: PUBCHEM.COMPOUND:22327742


subject: PUBCHEM.COMPOUND:22327742


subject: CHEBI:7465

subject_name: Naltrexone

object_name: endometriosis


subject: UNII:1W5N8SZD9A

subject_name: Glufosfamide

object_name: small cell lung carcinoma


subject: UMLS:C0242402

subject_name: Opioids

object_name: chronic obstructive pulmonary disease


subject: CHEBI:17303


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: Parkinson disease


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: Solid Neoplasm


subject: UMLS:C1962943

subject_name: krestin

object_name: Stomach cancer


subject: UMLS:C1962943

object_name: gastric cancer


subject: UNII:3X48A86C8K

subject_name: polysaccharide-K


subject: UNII:3X48A86C8K


subject: PR:000016049

subject_name: serine/threonine-protein kinase TAO2


subject: PR:000016049


subject: PR:000014729

subject_name: seizure 6-like protein 2


subject: PR:000014729


subject: PR:000015742

subject_name: serine/threonine-protein kinase 16


subject: PR:000015742


subject: CHEBI:229221

subject_name: Fruquintinib


subject: CHEBI:229221


subject: CHEBI:135349

subject_name: Mitiglinide

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: asthma


subject: PUBCHEM.COMPOUND:11431811

subject_name: Tiotropium Bromide Monohydrate


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: acute myocardial infarction


subject: CHEBI:3127

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:3127

object_name: ST-elevation myocardial infarction


subject: CHEBI:3127

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:3127

object_name: Non-ST Elevation Myocardial Infarction


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE


subject: PUBCHEM.COMPOUND:9800288


subject: PUBCHEM.COMPOUND:9800288


subject: PUBCHEM.COMPOUND:9800288


subject: PUBCHEM.COMPOUND:9800288


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:231693

subject_name: Capmatinib

object_name: non-small cell lung carcinoma


subject: UNII:KE7K32EME8

subject_name: Nazartinib


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Endometrial Intraepithelial Neoplasia


subject: PUBCHEM.COMPOUND:3080587

object_name: atypical endometrial hyperplasia


subject: PUBCHEM.COMPOUND:3080587

object_name: endometrium adenocarcinoma


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: CHEBI:6801


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: pneumonia


subject: CHEBI:100241

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: Safety Issues


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: T-Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:7XL5ISS668

object_name: anaplastic large cell lymphoma


subject: UNII:7XL5ISS668

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:7XL5ISS668

object_name: non-Hodgkin lymphoma


subject: UNII:7XL5ISS668

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:7XL5ISS668

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Carcinoma breast stage IV


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Postoperative Complications


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Human rabies


subject: CHEBI:6909

subject_name: Metronidazole


subject: PUBCHEM.COMPOUND:4454

subject_name: Neomycin sulfate


subject: UNII:057Y626693

subject_name: NEOMYCIN SULFATE


subject: CHEBI:31635

subject_name: neomycin sulfate


subject: CHEBI:7507

subject_name: Framycetin


subject: MESH:D011819

subject_name: Rabies Vaccines


subject: CHEMBL.COMPOUND:CHEMBL2107909

subject_name: RABIES VACCINE


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: MESH:C000627796

subject_name: Nano-PSO

object_name: Parkinson disease


subject: PR:000006898

object_name: colorectal cancer


subject: PR:000006898

object_name: colorectal carcinoma


subject: PR:000006898

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:63632

subject_name: Topotecan

object_name: small cell lung carcinoma


subject: CHEBI:63632

object_name: small cell carcinoma


subject: UNII:OGN7X90BT8

subject_name: Lenabasum

object_name: adult dermatomyositis


subject: UNII:OGN7X90BT8

object_name: dermatomyositis


subject: UMLS:C5854073


subject: UMLS:C5854073


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:21982135


subject: CHEBI:73038

subject_name: Parecoxib


subject: UNII:D07V79Q44T

object_name: glioma


subject: UNII:D07V79Q44T

object_name: malignant glioma


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:85990


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Dwarfism


subject: UNII:NQX9KB6PCL

object_name: Short stature


subject: UNII:NQX9KB6PCL

object_name: Short Stature, CTCAE


subject: UNII:NQX9KB6PCL

object_name: Psychosocial short stature


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0384570


subject: UMLS:C0384570


subject: UMLS:C0384570


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C2825029


subject: UMLS:C2825029


subject: UMLS:C2825029


subject: CHEBI:44915

subject_name: Propofol

object_name: no feeling or sensation of skin


subject: CHEBI:44915

object_name: Sensory Loss


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:133021

subject_name: Venetoclax

object_name: recurrent adult acute myeloid leukemia


subject: DRUGBANK:DB16630

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB16630

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB16630

object_name: Solid Neoplasm


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: atopic eczema


subject: CHEBI:231614

subject_name: Nivolumab

object_name: melanoma


subject: UMLS:C2346820


subject: UNII:96265TNH2R

subject_name: Gedatolisib

object_name: triple-negative breast carcinoma


subject: GTOPDB:8313

subject_name: talazoparib


subject: UMLS:C4058551

subject_name: Paliperidone ER

object_name: schizoaffective disorder


subject: UMLS:C4058551

object_name: schizophrenia 18


subject: UMLS:C4058551

object_name: psychosis


subject: UMLS:C4058551

object_name: Psychotic disorder due to a general medical condition


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: cocaine dependence


subject: CHEBI:41791

subject_name: calyculin A

object_name: plasma cell myeloma


subject: CHEBI:36025

subject_name: octadeca-9,11-dienoic acid


subject: CHEBI:61159

subject_name: conjugated linoleic acid


subject: CHEBI:3732

subject_name: Clarithromycin


subject: UNII:7DT29059VX


subject: CHEBI:35341

subject_name: steroid


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Cerebral venous thrombosis


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: thyroid tumor


subject: UMLS:C1881373

object_name: pregnancy related


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C1527137

object_name: Fatigue


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:167574

subject_name: Semaglutide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:167574

object_name: obesity


subject: CHEBI:167574

object_name: Obesity, CTCAE


subject: CHEBI:167574

object_name: Metabolic associated fatty liver disease


subject: UMLS:C3272509

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C3272509

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy

object_name: chronic hepatitis B virus infection


subject: PUBCHEM.COMPOUND:72370618

object_name: hepatitis B


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:52717

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: pterygium


subject: UNII:2S9ZZM9Q9V

object_name: conjunctival pterygium


subject: UNII:O519NVW73R

subject_name: Capadenoson

object_name: atrial fibrillation


subject: UNII:O519NVW73R

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:O519NVW73R

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C3501749


subject: UMLS:C3501749


subject: UMLS:C3501749


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: mantle cell lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:41879


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:31348

subject_name: Capecitabine

object_name: colorectal neoplasm


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib


subject: CHEBI:85164


subject: CHEBI:68606

subject_name: Rilpivirine

object_name: HIV infection


subject: CHEBI:34730

subject_name: doxycycline hyclate

object_name: euthyroid Graves orbitopathy


subject: CHEBI:34730

object_name: endocrine exophthalmos


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: Renal transplant rejection


subject: CHEBI:76018

subject_name: Riociguat

object_name: sarcoidosis


subject: CHEBI:76018

object_name: sarcoidosis, susceptibility to, 1


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: allergic asthma


subject: UMLS:C0910794


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: metastatic colorectal cancer


subject: UMLS:C0879636

subject_name: IMC C225


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:6067

subject_name: Isotretinoin


subject: MESH:D002214

subject_name: Capsules


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Carcinoma of urinary bladder, invasive


subject: CHEBI:73604

object_name: urinary bladder carcinoma


subject: CHEBI:73604

object_name: urinary bladder cancer


subject: UNII:2P471X1Z11

object_name: asthma


subject: UMLS:C0910794


subject: UNII:92T1Y5X038

subject_name: Florilglutamic acid F-18

object_name: cardiac sarcoidosis


subject: UNII:92T1Y5X038

object_name: myocarditis


subject: UMLS:C4053691


subject: UMLS:C4053691


subject: UMLS:C5139812


subject: UMLS:C5139812


subject: CHEBI:10125

subject_name: Zolpidem

object_name: Primary Insomnia


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:61057

object_name: vitiligo


subject: CHEBI:61057

object_name: skin pigmentation disorder


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Childhood Breast Carcinoma


subject: CHEBI:31348

object_name: breast carcinoma


subject: CHEBI:31348

object_name: breast cancer


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:95165

object_name: Refractory Acute Biphenotypic Leukemia


subject: CHEBI:95165

object_name: acute biphenotypic leukemia in relapse


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine

object_name: Refractory acute myeloid leukemia


subject: UNII:39IS23Q1EW

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: CHEBI:8499

subject_name: Propranolol

object_name: post-traumatic stress disorder


subject: CHEBI:8499

object_name: acute stress disorder


subject: CHEBI:8499

object_name: adjustment disorder


subject: CHEBI:8988

object_name: metastatic colorectal cancer


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:9150

subject_name: Simvastatin


subject: UNII:83G67E21XI

subject_name: Urokinase

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: UMLS:C0701941

subject_name: Abbokinase


subject: CHEBI:28680

subject_name: Cytarabine

object_name: leukemia


subject: CHEBI:28680

object_name: childhood leukemia


subject: CHEBI:28680

object_name: unspecified childhood solid tumor, protocol specific


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Hodgkin Disease


subject: UNII:KXG2PJ551I

object_name: Adult Hodgkin Lymphoma


subject: UNII:KXG2PJ551I

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:138376495

subject_name: Cefiderocol

object_name: bacterial infectious disease


subject: CHEBI:145994

subject_name: Remdesivir

object_name: Ebola hemorrhagic fever


subject: CHEBI:145994

object_name: AIDS


subject: CHEBI:4305

subject_name: dacarbazine

object_name: leiomyosarcoma of the corpus uteri


subject: CHEBI:4305

object_name: leiomyosarcoma


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEBI:33375


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: UMLS:C5446700

subject_name: Acapatamab

object_name: non-small cell lung carcinoma


subject: UNII:ZXM835LQ5E

subject_name: Uprosertib

object_name: cancer


subject: UNII:ZXM835LQ5E

object_name: neoplasm


subject: UMLS:C2830127


subject: UMLS:C2830127


subject: DRUGBANK:DB10636

subject_name: Raspberry

object_name: Prediabetes


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: graft versus host disease


subject: CHEBI:4026

object_name: Neoplasm, Residual


subject: CHEBI:4026

object_name: Chronic myeloid leukemia in remission


subject: CHEBI:4026

object_name: Chronic myelomonocytic leukaemia (in remission)


subject: CHEBI:4026

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:4026

object_name: Acute myeloid leukemia in remission


subject: CHEBI:4026

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:4026

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:4026

object_name: childhood myelodysplastic syndrome


subject: CHEBI:4026

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:4026

object_name: Severe Aplastic Anemia


subject: CHEBI:4026

object_name: severe aplastic anemia


subject: CHEBI:4026

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:4026

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:4026

object_name: non-Hodgkin lymphoma


subject: CHEBI:4026

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Hodgkin Disease


subject: CHEBI:4026

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: graft versus host disease


subject: CHEBI:4027

object_name: Neoplasm, Residual


subject: CHEBI:4027

object_name: Chronic myeloid leukemia in remission


subject: CHEBI:4027

object_name: Chronic myelomonocytic leukaemia (in remission)


subject: CHEBI:4027

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:4027

object_name: Acute myeloid leukemia in remission


subject: CHEBI:4027

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:4027

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:4027

object_name: childhood myelodysplastic syndrome


subject: CHEBI:4027

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:4027

object_name: Severe Aplastic Anemia


subject: CHEBI:4027

object_name: severe aplastic anemia


subject: CHEBI:4027

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:4027

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:4027

object_name: non-Hodgkin lymphoma


subject: CHEBI:4027

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:4027

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:4027

object_name: Hodgkin Disease


subject: CHEBI:4027

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:4027

object_name: Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: graft versus host disease


subject: PUBCHEM.COMPOUND:3368

object_name: Neoplasm, Residual


subject: PUBCHEM.COMPOUND:3368

object_name: Chronic myeloid leukemia in remission


subject: PUBCHEM.COMPOUND:3368

object_name: Chronic myelomonocytic leukaemia (in remission)


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: PUBCHEM.COMPOUND:3368

object_name: Acute myeloid leukemia in remission


subject: PUBCHEM.COMPOUND:3368

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:3368

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:3368

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:3368

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:3368

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:3368

object_name: Severe Aplastic Anemia


subject: PUBCHEM.COMPOUND:3368

object_name: severe aplastic anemia


subject: PUBCHEM.COMPOUND:3368

object_name: myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:3368

object_name: Malignant myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:3368

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:3368

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:63599

subject_name: Fludarabine

object_name: graft versus host disease


subject: CHEBI:63599

object_name: Neoplasm, Residual


subject: CHEBI:63599

object_name: Chronic myeloid leukemia in remission


subject: CHEBI:63599

object_name: Chronic myelomonocytic leukaemia (in remission)


subject: CHEBI:63599

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:63599

object_name: Acute myeloid leukemia in remission


subject: CHEBI:63599

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:63599

object_name: Myelodysplasia


subject: CHEBI:63599

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:63599

object_name: childhood myelodysplastic syndrome


subject: CHEBI:63599

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:63599

object_name: Severe Aplastic Anemia


subject: CHEBI:63599

object_name: severe aplastic anemia


subject: CHEBI:63599

object_name: myeloproliferative neoplasm


subject: CHEBI:63599

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:63599

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:63599

object_name: non-Hodgkin lymphoma


subject: CHEBI:63599

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:63599

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:63599

object_name: Hodgkin Disease


subject: CHEBI:63599

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:63599

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:28876

subject_name: Melphalan

object_name: graft versus host disease


subject: CHEBI:28876

object_name: Neoplasm, Residual


subject: CHEBI:28876

object_name: Chronic myeloid leukemia in remission


subject: CHEBI:28876

object_name: Chronic myelomonocytic leukaemia (in remission)


subject: CHEBI:28876

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:28876

object_name: Acute myeloid leukemia in remission


subject: CHEBI:28876

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:28876

object_name: Myelodysplasia


subject: CHEBI:28876

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:28876

object_name: childhood myelodysplastic syndrome


subject: CHEBI:28876

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:28876

object_name: Severe Aplastic Anemia


subject: CHEBI:28876

object_name: severe aplastic anemia


subject: CHEBI:28876

object_name: myeloproliferative neoplasm


subject: CHEBI:28876

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:28876

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:28876

object_name: non-Hodgkin lymphoma


subject: CHEBI:28876

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:28876

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:28876

object_name: Hodgkin Disease


subject: CHEBI:28876

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:28876

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: graft versus host disease


subject: CHEBI:168396

object_name: Neoplasm, Residual


subject: CHEBI:168396

object_name: Chronic myeloid leukemia in remission


subject: CHEBI:168396

object_name: Chronic myelomonocytic leukaemia (in remission)


subject: CHEBI:168396

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:168396

object_name: Acute myeloid leukemia in remission


subject: CHEBI:168396

object_name: plasma cell myeloma


subject: CHEBI:168396

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:168396

object_name: Myelodysplasia


subject: CHEBI:168396

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:168396

object_name: childhood myelodysplastic syndrome


subject: CHEBI:168396

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:168396

object_name: Severe Aplastic Anemia


subject: CHEBI:168396

object_name: severe aplastic anemia


subject: CHEBI:168396

object_name: myeloproliferative neoplasm


subject: CHEBI:168396

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:168396

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:168396

object_name: non-Hodgkin lymphoma


subject: CHEBI:168396

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:168396

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:168396

object_name: Hodgkin Disease


subject: CHEBI:168396

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:168396

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: graft versus host disease


subject: CHEBI:8764

object_name: Neoplasm, Residual


subject: CHEBI:8764

object_name: Chronic myeloid leukemia in remission


subject: CHEBI:8764

object_name: Chronic myelomonocytic leukaemia (in remission)


subject: CHEBI:8764

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:8764

object_name: Acute myeloid leukemia in remission


subject: CHEBI:8764

object_name: plasma cell myeloma


subject: CHEBI:8764

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:8764

object_name: Myelodysplasia


subject: CHEBI:8764

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:8764

object_name: childhood myelodysplastic syndrome


subject: CHEBI:8764

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:8764

object_name: Severe Aplastic Anemia


subject: CHEBI:8764

object_name: severe aplastic anemia


subject: CHEBI:8764

object_name: myeloproliferative neoplasm


subject: CHEBI:8764

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:8764

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:8764

object_name: non-Hodgkin lymphoma


subject: CHEBI:8764

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:8764

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:8764

object_name: Hodgkin Disease


subject: CHEBI:8764

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:8764

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: graft versus host disease


subject: CHEBI:9168

object_name: Neoplasm, Residual


subject: CHEBI:9168

object_name: Chronic myeloid leukemia in remission


subject: CHEBI:9168

object_name: Chronic myelomonocytic leukaemia (in remission)


subject: CHEBI:9168

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:9168

object_name: Acute myeloid leukemia in remission


subject: CHEBI:9168

object_name: plasma cell myeloma


subject: CHEBI:9168

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:9168

object_name: Myelodysplasia


subject: CHEBI:9168

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:9168

object_name: childhood myelodysplastic syndrome


subject: CHEBI:9168

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:9168

object_name: Severe Aplastic Anemia


subject: CHEBI:9168

object_name: severe aplastic anemia


subject: CHEBI:9168

object_name: myeloproliferative neoplasm


subject: CHEBI:9168

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:9168

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:9168

object_name: non-Hodgkin lymphoma


subject: CHEBI:9168

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Hodgkin Disease


subject: CHEBI:9168

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:9168

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C5206710

object_name: primary central nervous system lymphoma


subject: UMLS:C5206710

object_name: Secondary Central Nervous System Lymphoma


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: diabetic kidney disease


subject: CHEBI:28939

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:28939

object_name: type 2 diabetes mellitus


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Carcinoma breast stage IV


subject: CHEBI:231005

object_name: poisoning


subject: CHEBI:231005

object_name: Drug toxicity


subject: CHEBI:231005

object_name: neurotoxicity


subject: CHEBI:231005

object_name: Adverse drug response


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: UMLS:C3898588

subject_name: Liposomal Curcumin


subject: UMLS:C3898588

object_name: Insulin resistance


subject: UMLS:C3898588

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C4086550

subject_name: Pemlimogene merolisbac

object_name: non-small cell lung carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: ovarian carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: malignant epithelial tumor of ovary


subject: UNII:2S9ZZM9Q9V

object_name: fallopian tube carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: fallopian tube cancer


subject: UNII:2S9ZZM9Q9V

object_name: primary peritoneal carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Primary Peritoneal Cancer


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:16467

subject_name: Arginine

object_name: acute kidney failure


subject: CHEBI:16467

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: hypertension


subject: CHEBI:127342

object_name: Hypertension, CTCAE


subject: CHEBI:127342

object_name: obstructive sleep apnea syndrome


subject: CHEBI:3423

subject_name: Carmustine

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:3423

object_name: B-cell neoplasm


subject: CHEBI:3423

object_name: adult lymphoma


subject: CHEBI:3423

object_name: lymphoma


subject: CHEBI:3423

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:131174

subject_name: Navitoclax

object_name: prostate carcinoma


subject: CHEBI:131174

object_name: prostate cancer


subject: UMLS:C1831992

subject_name: ABT 263


subject: UMLS:C1831992


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Mycoses


subject: CHEBI:10023

object_name: leukemia


subject: CHEBI:10023

object_name: childhood leukemia


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: HER2 gene amplification


subject: UNII:PQX0D8J21J

object_name: Stage IV Rectal Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage III Rectal Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IIIC Colon Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Recurrent Rectal Cancer


subject: UNII:PQX0D8J21J

object_name: Stage III Colon Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IV Colon Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IIIB Colon Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVB Colon Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IVA Colon Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: rectum adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: Colon cancer recurrent


subject: UNII:PQX0D8J21J

object_name: colon adenocarcinoma


subject: UMLS:C0879636

subject_name: IMC C225

object_name: HER2 gene amplification


subject: UMLS:C0879636

object_name: Stage IV Rectal Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage III Rectal Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IIIC Colon Cancer AJCC v7


subject: UMLS:C0879636

object_name: Recurrent Rectal Cancer


subject: UMLS:C0879636

object_name: Stage III Colon Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IV Colon Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IIIB Colon Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IVB Colon Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IVA Colon Cancer AJCC v7


subject: UMLS:C0879636

object_name: rectum adenocarcinoma


subject: UMLS:C0879636

object_name: Colon cancer recurrent


subject: UMLS:C0879636

object_name: colon adenocarcinoma


subject: CHEBI:90881

subject_name: Camptosar

object_name: HER2 gene amplification


subject: CHEBI:90881

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:90881

object_name: Recurrent Rectal Cancer


subject: CHEBI:90881

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IIIB Colon Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:90881

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:90881

object_name: rectum adenocarcinoma


subject: CHEBI:90881

object_name: Colon cancer recurrent


subject: CHEBI:90881

object_name: colon adenocarcinoma


subject: CHEBI:8988

object_name: HER2 gene amplification


subject: CHEBI:8988

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:8988

object_name: Recurrent Rectal Cancer


subject: CHEBI:8988

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IIIB Colon Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:8988

object_name: rectum adenocarcinoma


subject: CHEBI:8988

object_name: Colon cancer recurrent


subject: CHEBI:8988

object_name: colon adenocarcinoma


subject: CHEBI:80630

subject_name: Irinotecan

object_name: HER2 gene amplification


subject: CHEBI:80630

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:80630

object_name: Recurrent Rectal Cancer


subject: CHEBI:80630

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IIIB Colon Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:80630

object_name: rectum adenocarcinoma


subject: CHEBI:80630

object_name: Colon cancer recurrent


subject: CHEBI:80630

object_name: colon adenocarcinoma


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: HER2 gene amplification


subject: UNII:K16AIQ8CTM

object_name: Stage IV Rectal Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage III Rectal Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage IIIC Colon Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Recurrent Rectal Cancer


subject: UNII:K16AIQ8CTM

object_name: Stage III Colon Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage IV Colon Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage IIIB Colon Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage IVB Colon Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: Stage IVA Colon Cancer AJCC v7


subject: UNII:K16AIQ8CTM

object_name: rectum adenocarcinoma


subject: UNII:K16AIQ8CTM

object_name: Colon cancer recurrent


subject: UNII:K16AIQ8CTM

object_name: colon adenocarcinoma


subject: CHEBI:231601

subject_name: trastuzumab

object_name: HER2 gene amplification


subject: CHEBI:231601

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:231601

object_name: Recurrent Rectal Cancer


subject: CHEBI:231601

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IIIB Colon Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:231601

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:231601

object_name: rectum adenocarcinoma


subject: CHEBI:231601

object_name: Colon cancer recurrent


subject: CHEBI:231601

object_name: colon adenocarcinoma


subject: UNII:SE2KH7T06F

object_name: HER2 gene amplification


subject: UNII:SE2KH7T06F

object_name: Stage IV Rectal Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage III Rectal Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IIIC Colon Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Recurrent Rectal Cancer


subject: UNII:SE2KH7T06F

object_name: Stage III Colon Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IV Colon Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IIIB Colon Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IVB Colon Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: Stage IVA Colon Cancer AJCC v7


subject: UNII:SE2KH7T06F

object_name: rectum adenocarcinoma


subject: UNII:SE2KH7T06F

object_name: Colon cancer recurrent


subject: UNII:SE2KH7T06F

object_name: colon adenocarcinoma


subject: UMLS:C0338204

subject_name: Herceptin

object_name: HER2 gene amplification


subject: UMLS:C0338204

object_name: Stage IV Rectal Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage III Rectal Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IIIC Colon Cancer AJCC v7


subject: UMLS:C0338204

object_name: Recurrent Rectal Cancer


subject: UMLS:C0338204

object_name: Stage III Colon Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IV Colon Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IIIB Colon Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IIIA Colon Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IVB Colon Cancer AJCC v7


subject: UMLS:C0338204

object_name: Stage IVA Colon Cancer AJCC v7


subject: UMLS:C0338204

object_name: rectum adenocarcinoma


subject: UMLS:C0338204

object_name: Colon cancer recurrent


subject: UMLS:C0338204

object_name: colon adenocarcinoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Philadelphia Chromosome


subject: PUBCHEM.COMPOUND:1805

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:1805

object_name: acute biphenotypic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: mixed phenotype acute leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: acute leukemia of ambiguous lineage


subject: PUBCHEM.COMPOUND:1805

object_name: acute lymphoblastic leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:233593

subject_name: Flumatinib


subject: CHEBI:233593

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:233593

object_name: acute myeloid leukemia


subject: CHEBI:233593


subject: CHEBI:233593


subject: CHEBI:233593


subject: CHEBI:233593


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: hereditary hemorrhagic telangiectasia


subject: UNII:QP166M390Q

subject_name: Ataciguat

object_name: aortic valve disease 2


subject: UNII:QP166M390Q

object_name: aortic stenosis


subject: UNII:QP166M390Q

object_name: aortic valve disease 3


subject: UNII:QP166M390Q

object_name: Stenosis of aorta


subject: UMLS:C1870724


subject: UMLS:C1870724


subject: UMLS:C1870724


subject: UMLS:C1870724


subject: UMLS:C0722264

subject_name: Ontak

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C0722264

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: CHEBI:5523

subject_name: Goserelin

object_name: invasive breast carcinoma


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C5206502

subject_name: Anti-CD33/CD3 Bispecific Antibody JNJ-67571244

object_name: Myelodysplasia


subject: UMLS:C5206502


subject: PUBCHEM.COMPOUND:20734893

subject_name: Fluticasone furoate

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:20734893

object_name: chronic obstructive pulmonary disease


subject: CHEBI:5134

subject_name: Fluticasone


subject: CHEBI:5134


subject: PUBCHEM.COMPOUND:21880659

subject_name: Vilanterol


subject: PUBCHEM.COMPOUND:21880659


subject: UMLS:C4732972

subject_name: CAVATAK

object_name: melanoma


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:135207

subject_name: Clofedanol

object_name: ovarian cancer


subject: CHEBI:135207

object_name: ovarian neoplasm


subject: CHEBI:135207

object_name: ovarian carcinoma


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: CHEBI:6801


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE

object_name: Hyperuricemia


subject: UNII:C137DTR5RG

object_name: Hyperuricemia, CTCAE


subject: UNII:C137DTR5RG

object_name: gout


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: CHEBI:28177


subject: UNII:WZ0PYQ6VLU

subject_name: TIGULIXOSTAT


subject: UNII:WZ0PYQ6VLU


subject: UNII:WZ0PYQ6VLU


subject: DRUGBANK:DB18799

subject_name: Tigulixostat


subject: DRUGBANK:DB18799


subject: DRUGBANK:DB18799


subject: PUBCHEM.COMPOUND:126931

object_name: asthma


subject: CHEBI:53237

subject_name: 4-sulfanilamidobenzoic acid


subject: PUBCHEM.COMPOUND:134461434

object_name: respiratory syncytial virus infectious disease


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Regional Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: PUBCHEM.COMPOUND:131769963

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: PUBCHEM.COMPOUND:131769963

object_name: Distal Urethral Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: posterior urethra cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Proximal Urethral Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Urethral Cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: urethral carcinoma associated with invasive bladder cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: bladder squamous cell carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: bladder adenocarcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage III Bladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Bladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Bladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Bladder cancer stage IV


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Bladder Cancer AJCC v6


subject: PUBCHEM.COMPOUND:131769963

object_name: Bladder cancer recurrent


subject: UNII:5XYK65KIGD

object_name: Regional Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: UNII:5XYK65KIGD

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: UNII:5XYK65KIGD

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: UNII:5XYK65KIGD

object_name: Distal Urethral Carcinoma


subject: UNII:5XYK65KIGD

object_name: posterior urethra cancer


subject: UNII:5XYK65KIGD

object_name: Proximal Urethral Carcinoma


subject: UNII:5XYK65KIGD

object_name: transitional cell carcinoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Urethral Cancer


subject: UNII:5XYK65KIGD

object_name: urethral carcinoma associated with invasive bladder cancer


subject: UNII:5XYK65KIGD

object_name: bladder squamous cell carcinoma


subject: UNII:5XYK65KIGD

object_name: bladder adenocarcinoma


subject: UNII:5XYK65KIGD

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: UNII:5XYK65KIGD

object_name: Stage III Bladder Cancer AJCC v8


subject: UNII:5XYK65KIGD

object_name: Stage IV Bladder Cancer AJCC v8


subject: UNII:5XYK65KIGD

object_name: Stage IV Bladder Cancer AJCC v7


subject: UNII:5XYK65KIGD

object_name: Bladder cancer stage IV


subject: UNII:5XYK65KIGD

object_name: Stage IV Bladder Cancer AJCC v6


subject: UNII:5XYK65KIGD

object_name: Bladder cancer recurrent


subject: CHEBI:50924

subject_name: Sorafenib

object_name: Regional Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:50924

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: CHEBI:50924

object_name: Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:50924

object_name: Distal Urethral Carcinoma


subject: CHEBI:50924

object_name: posterior urethra cancer


subject: CHEBI:50924

object_name: Proximal Urethral Carcinoma


subject: CHEBI:50924

object_name: transitional cell carcinoma


subject: CHEBI:50924

object_name: Recurrent Urethral Cancer


subject: CHEBI:50924

object_name: urethral carcinoma associated with invasive bladder cancer


subject: CHEBI:50924

object_name: bladder squamous cell carcinoma


subject: CHEBI:50924

object_name: bladder adenocarcinoma


subject: CHEBI:50924

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:50924

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:50924

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:50924

object_name: Stage IV Bladder Cancer AJCC v7


subject: CHEBI:50924

object_name: Bladder cancer stage IV


subject: CHEBI:50924

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:50924

object_name: Bladder cancer recurrent


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:4026

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:4026

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:4026

object_name: acute myeloid leukemia


subject: CHEBI:4026

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:4026

object_name: acute lymphoblastic leukemia


subject: CHEBI:4026

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:4026

object_name: myelofibrosis


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431

object_name: Myelodysplasia


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431

object_name: Hodgkin Disease


subject: CHEBI:201431

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:201431

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:16118

subject_name: Berberine

object_name: ulcerative colitis


subject: CHEBI:16118

object_name: inflammatory bowel disease 1


subject: UMLS:C1831925

object_name: neoplasm


subject: UMLS:C1831925

object_name: glioma


subject: UMLS:C1831925

object_name: malignant glioma


subject: UMLS:C1831925

object_name: colorectal cancer


subject: UMLS:C1831925

object_name: colorectal carcinoma


subject: UMLS:C1831925

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1831925

object_name: pancreatic neoplasm


subject: UMLS:C1831925

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1831925

object_name: malignant pancreatic neoplasm


subject: UMLS:C1831925

object_name: prostate carcinoma


subject: UMLS:C1831925

object_name: prostate cancer


subject: UMLS:C1831925

object_name: ovarian cancer


subject: UMLS:C1831925

object_name: ovarian neoplasm


subject: UMLS:C1831925

object_name: ovarian carcinoma


subject: UMLS:C1831925

object_name: Childhood Breast Carcinoma


subject: UMLS:C1831925

object_name: breast carcinoma


subject: UMLS:C1831925

object_name: breast cancer


subject: UMLS:C1831925

object_name: lung cancer


subject: UMLS:C1831925

object_name: lung neoplasm


subject: UMLS:C1831925

object_name: lung carcinoma


subject: CHEBI:78543

subject_name: Ponatinib

object_name: KIT Exon 13 Mutation


subject: CHEBI:78543

object_name: C-kit gene mutation


subject: CHEBI:78543

object_name: Plexosarcoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: proliferative diabetic retinopathy


subject: UNII:2S9ZZM9Q9V

object_name: background diabetic retinopathy


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Antibody-mediated rejection


subject: CHEBI:3423

subject_name: Carmustine

object_name: diffuse large B-cell lymphoma


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: UMLS:C0733524

subject_name: Aracytine


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:6775

subject_name: Mesalazine

object_name: ulcerative colitis


subject: CHEBI:6775

object_name: inflammatory bowel disease 1


subject: CHEBI:17290

subject_name: (S)-3-hydroxybutyric acid

object_name: Critical Illness


subject: CHEBI:37054


subject: UMLS:C0106006


subject: PUBCHEM.COMPOUND:157364

subject_name: Vamin


subject: UMLS:C0148151


subject: UNII:768FW21J3L

subject_name: Famitinib


subject: UMLS:C5555006


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Acute Stroke


subject: UNII:0OJB0LES1A

object_name: type 2 diabetes mellitus


subject: CHEBI:145499

subject_name: Donepezil

object_name: Postoperative Complications


subject: CHEBI:145499

object_name: delirium


subject: CHEBI:145499

object_name: Delirium, CTCAE


subject: CHEBI:18258

subject_name: Liothyronine

object_name: thyroid tumor


subject: CHEBI:18258

object_name: pneumonitis


subject: CHEBI:18258

object_name: pneumonia


subject: CHEBI:18258

object_name: acute respiratory distress syndrome


subject: CHEBI:18258

object_name: pulmonary edema


subject: CHEBI:18258

object_name: Pulmonary Edema, CTCAE


subject: UMLS:C0010826

subject_name: Cytomel


subject: UMLS:C0010826


subject: UMLS:C0010826


subject: UMLS:C0010826


subject: UMLS:C0010826


subject: UMLS:C0010826


subject: UMLS:C2936843

subject_name: l-Triiodothyronine [EPC]


subject: UMLS:C2936843


subject: UMLS:C2936843


subject: UMLS:C2936843


subject: UMLS:C2936843


subject: UMLS:C2936843


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:26710


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: EXCESS LMW-DNA


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C2349988

subject_name: Myobacterium w (attenuated)

object_name: bladder tumor


subject: UMLS:C2349988

object_name: urinary bladder carcinoma


subject: UMLS:C2349988

object_name: urinary bladder cancer


subject: UMLS:C2349988

object_name: childhood bladder carcinoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Surgical procedure finding


subject: CHEBI:60802


subject: CHEBI:3223

subject_name: Buspirone

object_name: cannabis abuse


subject: CHEBI:3223

object_name: mood disorder


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Immunosuppression


subject: PUBCHEM.COMPOUND:70789204

object_name: Decreased Immunologic Activity [PE]


subject: PUBCHEM.COMPOUND:70789204

object_name: kidney failure


subject: PUBCHEM.COMPOUND:70789204

object_name: Renal Failure, CTCAE


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Myelodysplasia


subject: UMLS:C5236066

subject_name: Anti-GFRAL Monoclonal Antibody NGM120

object_name: Cachexia


subject: CHEBI:173763

subject_name: Thermophillin

object_name: alcohol abuse


subject: CHEBI:173763

object_name: alcohol dependence


subject: CHEBI:173763

object_name: anxiety disorder


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: PUBCHEM.COMPOUND:23597337


subject: PUBCHEM.COMPOUND:23597337


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:52993

subject_name: Lormetazepam


subject: CHEBI:52993


subject: CHEBI:6539

subject_name: Lorazepam


subject: CHEBI:6539


subject: PUBCHEM.COMPOUND:100154

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: actinic cheilitis


subject: CHEBI:91872

object_name: malignant mesothelioma


subject: CHEBI:91872

object_name: lung cancer


subject: CHEBI:91872

object_name: lung neoplasm


subject: CHEBI:91872

object_name: lung carcinoma


subject: CHEBI:91872

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:91872

object_name: Embolism, Tumor


subject: CHEBI:91872

object_name: Neoplasm Metastasis


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:63577

subject_name: Lamivudine

object_name: rhegmatogenous retinal detachment


subject: CHEBI:63577

object_name: retinal detachment


subject: CHEBI:63577

object_name: Retinal Detachment, CTCAE 3.0


subject: CHEBI:63577

object_name: Retinal Detachment, CTCAE 5.0


subject: CHEBI:31550

subject_name: Patupilone

object_name: neoplasm


subject: UMLS:C1328655


subject: UNII:U7GBB0934J

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:U7GBB0934J


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: lichen planus, oral


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: HMDB:HMDB0255819

subject_name: Nusinersen

object_name: spinal muscular atrophy


subject: HMDB:HMDB0255819

object_name: proximal spinal muscular atrophy


subject: CHEBI:31174

subject_name: Adapalene

object_name: acne


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Adult Solid Neoplasm


subject: UNII:28X28X9OKV

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:28X28X9OKV

object_name: Advanced Pancreatic Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Advanced Colorectal Carcinoma


subject: UNII:28X28X9OKV

object_name: Advanced Soft Tissue Sarcoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:231598

subject_name: Tazemetostat


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: UNII:2BTA1O65BR

object_name: head and neck squamous cell carcinoma


subject: UNII:2BTA1O65BR

object_name: Neck Carcinoma


subject: UNII:2BTA1O65BR

object_name: head and neck neoplasm


subject: UNII:2BTA1O65BR

object_name: head and neck cancer


subject: UNII:2BTA1O65BR

object_name: cervical cancer


subject: UNII:2BTA1O65BR

object_name: cervical carcinoma


subject: UNII:2BTA1O65BR

object_name: lung cancer


subject: UNII:2BTA1O65BR

object_name: lung neoplasm


subject: UNII:2BTA1O65BR

object_name: lung carcinoma


subject: UNII:2BTA1O65BR

object_name: colorectal cancer


subject: UNII:2BTA1O65BR

object_name: colorectal carcinoma


subject: UNII:2BTA1O65BR

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:2BTA1O65BR

object_name: ovarian cancer


subject: UNII:2BTA1O65BR

object_name: ovarian neoplasm


subject: UNII:2BTA1O65BR

object_name: ovarian carcinoma


subject: UNII:2BTA1O65BR

object_name: peritoneum cancer


subject: UNII:2BTA1O65BR

object_name: endometrial cancer


subject: UNII:2BTA1O65BR

object_name: uterine corpus cancer


subject: UNII:2BTA1O65BR

object_name: endometrial carcinoma


subject: UNII:2BTA1O65BR

object_name: pancreatic neoplasm


subject: UNII:2BTA1O65BR

object_name: exocrine pancreatic carcinoma


subject: UNII:2BTA1O65BR

object_name: malignant pancreatic neoplasm


subject: UNII:2BTA1O65BR

object_name: fallopian tube carcinoma


subject: UNII:2BTA1O65BR

object_name: fallopian tube cancer


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: UMLS:C5556565

subject_name: Nanoparticles Encapsulating TLR7 Agonist 1v270 MBS8

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:90943

subject_name: Osimertinib

object_name: Non-small cell lung cancer stage I


subject: UNII:2S27T3DSZ3

object_name: hypertension


subject: UNII:2S27T3DSZ3

object_name: Hypertension, CTCAE


subject: UMLS:C0936150

subject_name: artemether / lumefantrine

object_name: malaria


subject: UMLS:C0936150

object_name: HIV infection


subject: CHEBI:73770

subject_name: Ala-Leu


subject: CHEBI:73770


subject: CHEBI:73838

subject_name: D-Ala-Leu


subject: CHEBI:73838


subject: CHEBI:30136

subject_name: Aluminium


subject: CHEBI:30136


subject: CHEBI:28984

subject_name: aluminium atom


subject: CHEBI:28984


subject: MESH:C086083


subject: MESH:C086083


subject: CHEBI:6801

subject_name: Metformin

object_name: atrial fibrillation


subject: CHEBI:6801

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:6801

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C5209358

subject_name: Rohto Dry-Aid

object_name: dry eye syndrome


subject: UMLS:C5209358

object_name: Dry Eye, CTCAE


subject: UMLS:C5209358

object_name: Dryness of eye


subject: UMLS:C5854514

subject_name: Mutated Human Nerve Growth Factor CHF6467

object_name: optic pathway glioma


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: UMLS:C0012964

subject_name: Dobutrex

object_name: wild type ATTR amyloidosis


subject: CHEBI:4670

subject_name: Dobutamine


subject: CHEBI:59773

subject_name: CROMOLYN

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:59773

object_name: amyotrophic lateral sclerosis


subject: UNII:06CA9QMG6Z

object_name: endogenous depression


subject: UNII:06CA9QMG6Z

object_name: major depressive disorder


subject: UMLS:C5433654


subject: UMLS:C5433654


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: vasculitis


subject: UNII:37CQ2C7X93

object_name: Vasculitis, CTCAE


subject: UNII:37CQ2C7X93

object_name: urticaria


subject: UNII:37CQ2C7X93

object_name: reported urticaria (physical finding)


subject: UNII:37CQ2C7X93

object_name: Urticaria, CTCAE


subject: UMLS:C2718754

subject_name: Ilaris


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: CHEBI:134964

subject_name: Perflubutane

object_name: focal nodular hyperplasia


subject: CHEBI:134964

object_name: Hepatic focal nodular hyperplasia


subject: MESH:C069727

subject_name: Sonazoid


subject: MESH:C069727


subject: PUBCHEM.COMPOUND:78092786

subject_name: Etelcalcetide

object_name: secondary hyperparathyroidism


subject: UMLS:C3712398


subject: UMLS:C3640095

subject_name: CD-expressing Bifidobacterium APS001F

object_name: neoplasm


subject: UMLS:C3640095

object_name: cancer


subject: CHEBI:5100

subject_name: Flucytosine


subject: CHEBI:5100


subject: CHEBI:6804

subject_name: Methacholine

object_name: asthma


subject: CHEBI:9445

subject_name: Terazosin

object_name: secondary Parkinson disease


subject: CHEBI:9445

object_name: REM sleep behavior disorder


subject: CHEMBL.COMPOUND:CHEMBL2109092

subject_name: EPOETIN BETA

object_name: anemia


subject: CHEMBL.COMPOUND:CHEMBL2109092

object_name: Anemia, CTCAE


subject: CHEBI:17234

subject_name: D-glucose

object_name: Ketosis


subject: CHEBI:17234

object_name: Ketoacidosis


subject: CHEBI:17234

object_name: digestive system infectious disorder


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Agitation, CTCAE 3.0


subject: CHEBI:119915

object_name: Agitation


subject: CHEBI:119915

object_name: Agitation, CTCAE 5.0


subject: CHEMBL.COMPOUND:CHEMBL1743016

subject_name: FARLETUZUMAB

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL1743016

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743016

object_name: ovarian carcinoma


subject: UMLS:C1831845


subject: UMLS:C1831845


subject: UMLS:C1831845


subject: UMLS:C3529795

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3529795

object_name: non-Hodgkin lymphoma


subject: UMLS:C3529795

object_name: follicular lymphoma


subject: UMLS:C3529795

object_name: diffuse large B-cell lymphoma


subject: UMLS:C3529795

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3529795

object_name: renal cell carcinoma


subject: UMLS:C3529795

object_name: melanoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6

object_name: non-small cell lung carcinoma


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:4798

subject_name: Entacapone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:4798

object_name: obesity


subject: CHEBI:4798

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:155180028

object_name: neurodevelopmental disorder


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Carcinoma breast stage IV


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Prevention problem


subject: CHEBI:68579

object_name: venous thromboembolism


subject: CHEBI:68579

object_name: thrombophilia due to thrombin defect


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: CHEBI:39548

object_name: Pathologic Stage IIB Cutaneous Melanoma AJCC v8


subject: CHEBI:39548

object_name: Pathologic Stage IIA Cutaneous Melanoma AJCC v8


subject: UMLS:C2069096

subject_name: Norethindrone Acetate and Ethinyl Estradiol

object_name: Oxytocin deficiency


subject: UMLS:C2069096

object_name: central diabetes insipidus


subject: UMLS:C2069096

object_name: neurohypophyseal diabetes insipidus


subject: PUBCHEM.COMPOUND:544190

object_name: influenza


subject: CHEBI:7798

subject_name: Oseltamivir


subject: UNII:1351PE5UGS

subject_name: Elotuzumab

object_name: plasma cell myeloma


subject: GTOPDB:9310

subject_name: lirilumab


subject: UNII:S9XDI9W918

subject_name: LIRILUMAB


subject: UMLS:C3641620


subject: GTOPDB:9311

subject_name: urelumab


subject: CHEMBL.COMPOUND:CHEMBL1743085

subject_name: URELUMAB


subject: UMLS:C1831875


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: melanoma


subject: UMLS:C3827149


subject: UNII:HM5641GA6F

subject_name: Oprelvekin

object_name: pancytopenia due to chemotherapy


subject: UMLS:C0537668

subject_name: Neumega


subject: CHEBI:17710

subject_name: Mevalonic acid

object_name: HIV infection


subject: DRUGBANK:DB15483

subject_name: Modified vaccinia ankara


subject: PUBCHEM.COMPOUND:4953

subject_name: (15S)-Prostaglandin A2


subject: CHEBI:133370

subject_name: Prostaglandin 2


subject: CHEBI:27820


subject: PUBCHEM.COMPOUND:5353901

subject_name: Prostaglandin A-2


subject: UMLS:C4726994

subject_name: AXL Inhibitor DS-1205c

object_name: non-small cell lung carcinoma


subject: CHEBI:44915

subject_name: Propofol

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:94531

subject_name: belinostat

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:94531

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C0125069

subject_name: L-ornithine L-aspartate

object_name: Hepatic encephalopathy stage 2


subject: UMLS:C0125069

object_name: Hepatic encephalopathy stage 4


subject: UMLS:C0125069

object_name: Hepatic encephalopathy stage 3


subject: CHEBI:30742

subject_name: macrogol


subject: CHEBI:30742


subject: CHEBI:30742


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290

object_name: vitamin C measurement


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UNII:PX665RAA3H

subject_name: Ensitrelvir

object_name: long COVID-19


subject: CHEBI:41423

subject_name: Celecoxib

object_name: breast carcinoma


subject: UMLS:C4733690

subject_name: BTK Inhibitor ICP-022


subject: CHEBI:6427

subject_name: Leuprolide

object_name: pedophilia


subject: CHEBI:4672

subject_name: Docetaxel

object_name: SMARCA4 Gene Mutation


subject: PUBCHEM.COMPOUND:168152471

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:168152471

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:168152471


subject: UMLS:C5854363

subject_name: SMARCA2 Degrader PRT3789


subject: UMLS:C5854363


subject: UMLS:C5854363


subject: PUBCHEM.COMPOUND:155586901

object_name: Metastatic Castration-Sensitive Prostate Carcinoma


subject: DRUGBANK:DB18982

subject_name: Saruparib


subject: MESH:D022341

subject_name: Yellow Fever Vaccine

object_name: yellow fever


subject: UMLS:C5887900

subject_name: Yellow fever virus antigen only vaccine product


subject: CHEMBL.COMPOUND:CHEMBL2108816

subject_name: YELLOW FEVER VACCINE


subject: UMLS:C2356374

subject_name: yellow fever virus strain 17D-204 live antigen


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: Recurrent Malignant Glioma


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: UMLS:C0027866

subject_name: Neuromuscular Blocking Agents

object_name: Neuromuscular inhibition


subject: UMLS:C0027866

object_name: Neuromuscular block, function


subject: UNII:SWS48LJU3T

subject_name: LIRENTELIMAB

object_name: eosinophilic esophagitis


subject: UNII:SWS48LJU3T

object_name: Eosinophilic infiltration of the esophagus


subject: UMLS:C4330704


subject: UMLS:C4330704


subject: CHEBI:49668

subject_name: Gefitinib

object_name: salivary gland carcinoma


subject: CHEBI:49668

object_name: salivary gland cancer


subject: PUBCHEM.COMPOUND:23083982

subject_name: Elvitegravir

object_name: bone disorder


subject: PUBCHEM.COMPOUND:23083982

object_name: Injury of kidney


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat


subject: PUBCHEM.COMPOUND:24950485


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:31536


subject: UNII:4YL3GT1EV9

object_name: panic disorder


subject: UNII:4YL3GT1EV9

object_name: panic disorder 1


subject: UMLS:C1872494


subject: UMLS:C1872494


subject: UNII:65V47O9NOP

object_name: cognitive disorder


subject: UNII:65V47O9NOP

object_name: Cognitive impairment


subject: UMLS:C4742765

object_name: Alzheimer disease


subject: CHEBI:184472

subject_name: Nitrofurantoin

object_name: urinary tract infection


subject: PUBCHEM.COMPOUND:157010100

subject_name: Potassium citrate


subject: UMLS:C5557461

object_name: COPD, severe early onset


subject: UMLS:C5557461

object_name: chronic obstructive pulmonary disease


subject: CHEBI:52172

subject_name: Nilotinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C1327844

object_name: papilloma


subject: UMLS:C1327844

object_name: recurrent respiratory papillomatosis


subject: UMLS:C4305930

object_name: Excessive somnolence


subject: CHEBI:166520

subject_name: Tenamfetamine

object_name: malaria


subject: CHEBI:32506


subject: CHEBI:566274

subject_name: Malonaldehyde


subject: CHEBI:16108

subject_name: Dihydroxyacetone phosphate


subject: PUBCHEM.COMPOUND:3086655

subject_name: Tiotropium

object_name: bronchiectasis


subject: PUBCHEM.COMPOUND:3086655

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:11431811

subject_name: Tiotropium Bromide Monohydrate


subject: PUBCHEM.COMPOUND:11431811


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:5147


subject: CHEBI:5147


subject: CHEBI:3638

subject_name: Chloroquine

object_name: tuberculosis


subject: CHEBI:3638

object_name: latent tuberculosis infection


subject: CHEBI:91899

object_name: Atopic rhinitis


subject: CHEBI:91899

object_name: Hay fever


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:114785

subject_name: Erlotinib

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:114785

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:114785

object_name: Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11


subject: CHEBI:114785

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:114785

object_name: Alkylating Agent-Related Acute Myeloid Leukemia


subject: CHEBI:114785

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:114785

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:114785

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:114785

object_name: chronic myelomonocytic leukemia


subject: CHEBI:114785

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:114785

object_name: Myelodysplasia


subject: CHEBI:114785

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:114785

object_name: childhood myelodysplastic syndrome


subject: CHEBI:114785

object_name: Myelodysplastic Syndrome, CTCAE


subject: GTOPDB:7785

subject_name: mavrilimumab


subject: GTOPDB:7785

object_name: pneumonia


subject: GTOPDB:7785

object_name: COVID-19-Associated Pneumonia


subject: UNII:1158JD1P9A


subject: UNII:1158JD1P9A


subject: UNII:1158JD1P9A


subject: UMLS:C2987425


subject: UMLS:C2987425


subject: UMLS:C2987425


subject: CHEBI:151315

subject_name: Heparin

object_name: protein S deficiency


subject: CHEBI:151315

object_name: pregnancy related


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: MESH:C000718012

subject_name: sucrosomial iron

object_name: anemia


subject: MESH:C000718012

object_name: Anemia, CTCAE


subject: UMLS:C5544915


subject: UMLS:C5544915


subject: CHEBI:74947

subject_name: Thalidomide

object_name: sclerosing cholangitis


subject: CHEBI:74947

object_name: primary sclerosing cholangitis


subject: CHEBI:490877

subject_name: Didanosine

object_name: HIV infection


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Malignant neoplasm of female breast


subject: CHEBI:31348

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: invasive breast carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: DRUGBANK:DB17658

object_name: glycogen storage disease II


subject: UNII:F60NE4XB53

subject_name: imetelstat

object_name: myelofibrosis


subject: CHEBI:73604

subject_name: Lys-Gly


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:155543961

object_name: Diastolic dysfunction


subject: PUBCHEM.COMPOUND:155543961

object_name: maturity-onset diabetes of the young type 1


subject: PUBCHEM.COMPOUND:155543961

object_name: Fatty Liver


subject: PUBCHEM.COMPOUND:155543961

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:155543961

object_name: metabolic syndrome X


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:50453

subject_name: desferrioxamine

object_name: Problem of aging


subject: CHEBI:50453

object_name: stroke disorder


subject: CHEBI:50453

object_name: cerebrovascular disorder


subject: CHEBI:50453

object_name: Stroke (heart beat)


subject: CHEBI:50453

object_name: Stroke, CTCAE


subject: CHEBI:4356

subject_name: Deferoxamine


subject: CHEBI:4356


subject: CHEBI:4356


subject: CHEBI:4356


subject: CHEBI:4356


subject: CHEBI:60654

subject_name: valproate

object_name: heavy drinking


subject: CHEBI:60654

object_name: Physical trauma


subject: CHEBI:60654

object_name: Injury


subject: CHEBI:60654

object_name: Trauma


subject: CHEBI:60654

object_name: alcohol withdrawal


subject: CHEBI:60654

object_name: alcohol abuse


subject: CHEBI:60654

object_name: alcohol dependence


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: mantle cell lymphoma


subject: CHEBI:135515

subject_name: Bendamustine


subject: CHEBI:15640

subject_name: Leucovorin

object_name: carcinoma of esophagus


subject: CHEBI:15640

object_name: esophageal cancer


subject: CHEBI:15640

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:15640

object_name: neoplasm of esophagus


subject: PUBCHEM.COMPOUND:254731

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:254731

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:254731


subject: PUBCHEM.COMPOUND:254731


subject: PUBCHEM.COMPOUND:254731


subject: PUBCHEM.COMPOUND:254731


subject: PUBCHEM.COMPOUND:23279496

subject_name: uridine triacetate


subject: PUBCHEM.COMPOUND:23279496


subject: PUBCHEM.COMPOUND:23279496


subject: PUBCHEM.COMPOUND:23279496


subject: PUBCHEM.COMPOUND:23279496


subject: PUBCHEM.COMPOUND:23279496


subject: PUBCHEM.COMPOUND:130312

subject_name: sulperazone

object_name: secondary biliary cirrhosis


subject: PUBCHEM.COMPOUND:130312

object_name: Antibodies drug specific


subject: PUBCHEM.COMPOUND:16170201

subject_name: TEICOPLANIN


subject: PUBCHEM.COMPOUND:16170201


subject: UMLS:C4039583

subject_name: Chimeric antigen receptor

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4039583

object_name: non-Hodgkin lymphoma


subject: UMLS:C4547387

object_name: hypersomnia


subject: UMLS:C4547387

object_name: narcolepsy


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: atopic eczema


subject: CHEBI:184644

subject_name: dantrolene sodium hemiheptahydrate

object_name: Wolfram syndrome


subject: CHEBI:184644

object_name: diabetes mellitus


subject: CHEBI:184644

object_name: optic atrophy


subject: CHEBI:184644

object_name: Ataxia


subject: CHEBI:184644

object_name: atactic disorder


subject: CHEBI:184644

object_name: Ataxia as late effect of cerebrovascular disease


subject: CHEBI:184644

object_name: Dyssynergia


subject: CHEBI:184644

object_name: Ataxia, CTCAE_5


subject: CHEBI:4318

subject_name: Dantrolene Na


subject: CHEBI:4318


subject: CHEBI:4318


subject: CHEBI:4318


subject: CHEBI:4318


subject: CHEBI:4318


subject: CHEBI:4318


subject: CHEBI:4318


subject: UNII:F64QU97QCR

subject_name: Dantrolene


subject: UNII:F64QU97QCR


subject: UNII:F64QU97QCR


subject: UNII:F64QU97QCR


subject: UNII:F64QU97QCR


subject: UNII:F64QU97QCR


subject: UNII:F64QU97QCR


subject: UNII:F64QU97QCR


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: cervical cancer


subject: UNII:PQX0D8J21J

object_name: cervical carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: PR:000002033

subject_name: band 3 anion transport protein

object_name: heart failure


subject: PR:000002033

object_name: Heart Failure, CTCAE


subject: CHEBI:62097


subject: CHEBI:62097


subject: CHEBI:33367

subject_name: darmstadtium


subject: CHEBI:33367


subject: CHEBI:34699

subject_name: diethyl sulfate


subject: CHEBI:34699


subject: CHEBI:73454

subject_name: Asp-Ser


subject: CHEBI:73454


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:4659


subject: CHEBI:35498

subject_name: diuretic


subject: CHEBI:35498


subject: UMLS:C0012798

subject_name: Diuretics


subject: UMLS:C0012798


subject: UMLS:C5399719

subject_name: Diuretic [APC]


subject: UMLS:C5399719


subject: CHEBI:17437

subject_name: Dimethylsulfide


subject: CHEBI:17437


subject: CHEBI:59050

subject_name: dimethyl sulfate


subject: CHEBI:59050


subject: CHEBI:78759

subject_name: N,N-dimethylsphingosine


subject: CHEBI:78759


subject: CHEBI:63623

subject_name: Succimer


subject: CHEBI:63623


subject: UNII:0BSC3P4H5X

subject_name: Vistusertib

object_name: small cell lung carcinoma


subject: UMLS:C2981846


subject: DRUGBANK:DB16515

object_name: interstitial lung disease 1


subject: DRUGBANK:DB16515

object_name: interstitial lung disease 2


subject: CHEBI:27732

subject_name: Caffeine

object_name: Hypercapnia


subject: UMLS:C2830057

subject_name: c-Met/VEGFR-2 Kinase Inhibitor E7050

object_name: Stomach cancer


subject: UMLS:C2830057

object_name: gastric cancer


subject: UMLS:C2830057

object_name: Childhood Solid Neoplasm


subject: UMLS:C2830057

object_name: Adult Solid Neoplasm


subject: UMLS:C2830057

object_name: Solid Neoplasm


subject: CHEBI:201491

subject_name: Amoxicillin Clavulanate

object_name: Acute follicular tonsillitis


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: asthma


subject: CHEBI:18132

subject_name: phosphocholine

object_name: diffuse large B-cell lymphoma


subject: CHEBI:18132

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:18132

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UniProtKB:Q62857

subject_name: DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


subject: UniProtKB:Q62857


subject: UniProtKB:Q62857


subject: PR:000006347

subject_name: DNA damage-inducible transcript 3 protein


subject: PR:000006347


subject: PR:000006347


subject: CHEBI:9468

subject_name: Tetracaine

object_name: Corneal Abrasions


subject: UMLS:C4759828

object_name: prostate carcinoma


subject: UMLS:C4759828

object_name: prostate cancer


subject: CHEBI:28918

subject_name: Epinephrine

object_name: osteoarthritis, knee


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine


subject: CHEBI:31355

subject_name: Carboplatin

object_name: triple-negative breast carcinoma


subject: CHEBI:31355

object_name: Triple-Negative Breast Cancer Finding


subject: PUBCHEM.COMPOUND:46874763


subject: PUBCHEM.COMPOUND:46874763


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: CHEBI:63611


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: alopecia areata


subject: CHEBI:71200

object_name: alopecia


subject: PUBCHEM.COMPOUND:71271414

object_name: schizophrenia


subject: UNII:7M430JI73B


subject: GTOPDB:6749

subject_name: fibrinogen

object_name: Intraoperative Hemorrhage


subject: KEGG.COMPOUND:C00393

subject_name: Fibrinogen


subject: UMLS:C3540039

subject_name: Fibrinogen containing hemostatics


subject: UMLS:C2587184

subject_name: Parenogen


subject: UMLS:C0016006


subject: GTOPDB:4453

subject_name: thrombin


subject: CHEBI:9574

subject_name: Thrombin


subject: UMLS:C1337342

subject_name: thrombin, bovine


subject: UMLS:C0040018


subject: UMLS:C1871272

subject_name: TachoSil


subject: UMLS:C5565911

object_name: Myasthenia Gravis, Generalized


subject: CHEBI:9168

subject_name: Sirolimus

object_name: neoplasm


subject: CHEBI:38940

subject_name: Sunitinib


subject: UMLS:C3890420

subject_name: Realgar-Indigo naturalis Formulation

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:59495

subject_name: CIDOFOVIR

object_name: cytomegalovirus retinitis


subject: CHEBI:59495

object_name: AIDS


subject: CHEBI:530615


subject: CHEBI:530615


subject: CHEBI:134514


subject: CHEBI:134514


subject: CHEBI:3696

subject_name: Cidofovir


subject: CHEBI:3696


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: heart failure


subject: CHEBI:16347

object_name: Heart Failure, CTCAE


subject: CHEBI:149504

object_name: acoustic neuroma


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: coronary microvascular disorder


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: lung adenocarcinoma


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724

object_name: lung cancer


subject: CHEBI:63724

object_name: lung neoplasm


subject: CHEBI:63724

object_name: lung carcinoma


subject: CHEBI:63724


subject: CHEBI:31355

subject_name: Carboplatin


subject: MESH:D002214

subject_name: Capsules


subject: MESH:D002214


subject: MESH:D002214


subject: MESH:D002214


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: arteriosclerosis disorder


subject: CHEBI:168396

object_name: atherosclerosis


subject: CHEBI:168396

object_name: EXCESS LMW-DNA


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:28001

subject_name: Vancomycin

object_name: Clostridium difficile colitis


subject: CHEBI:28001

object_name: clostridium difficile infection


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: HER2 positive breast carcinoma


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:95341

subject_name: Baricitinib

object_name: allergic contact dermatitis


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Duchenne muscular dystrophy


subject: CHEBI:71940

object_name: muscular dystrophy


subject: CHEBI:71940

object_name: Vasodilation disorder


subject: CHEBI:71940

object_name: Muscular dystrophy in children


subject: CHEBI:71940

object_name: tabes dorsalis


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Prehypertension